Camena Bioscience Closes £7.8M Series A Funding Round
Summary
Camena Bioscience, a Cambridge, UK-based provider of synthetic genes to the pharmaceutical and biotechnology industries, raised £7.8M in Series A funding. Experienced biotechnology inventor and executive Aditya Rajagopal, founder of diagnostics company ChromaCode Inc and co-founder of Esperto Medical, and Lee Lindley, who has nearly 10 years of corporate finance and investing experience, has also joined the board. The company intends to use the funds to scale operations and continue development of its DNA synthesis platform, gSynth. Co-founded by CEO Steve Harvey and CSO Derek Stemple, Camena has developed enzyme-based DNA synthesis technology, which aims to overcome limitations of traditional DNA synthesis methods to accurately produce synthetic DNA. The company has already signed commercial agreements with biotech and pharmaceutical companies and secured a multi-million pound revenue stream.